Concepedia

Verity Sabin

VS

Statistics

Publications

21

Citations

533

H-Index

17

Active since

1992

Affiliations

Granta Design (United Kingdom)(Current)

UCB Pharma (United Kingdom)

University of Bradford

Merck & Co., Inc., Rahway, NJ, USA (United States)

Cancer Research UK

Verity Sabin is an author at Granta Design (United Kingdom) specializing in medicinal chemistry, pharmacology, and enzyme inhibition.

Publications per year

1992–2019

21

Publications

21

IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding

George M. Buckley, T.A. Ceska, Joanne L. Fraser et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 52 citations · Full text

, , +15

IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines

George M. Buckley, Richard Fosbeary, Joanne L. Fraser et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

, , +11

IRAK-4 inhibitors. Part 1: A series of amides

George M. Buckley, Lewis Gowers, Alícia P. Higueruelo et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 37 citations · Full text

, , +8

PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer

Angélica Santiago-Gómez, Thomas Kedward, Bruno M. Simões et al. · Cancer Letters · 2019 · 31 citations · Full text

, , +17

Synthesis of novel substituted isoquinolones

Nicolas Briet, Michael H. Brookes, Richard Davenport et al. · Tetrahedron · 2002 · 29 citations

, , +10

1–5 of 21